Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
Orchestra BioMed Holdings, Inc.'s stock currently trades at $3.83 with a market capitalization of $257.8M. The Healthcare company's stock moved following the disclosure.